<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d1 20130915//EN" "JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta id="journal-meta-8e74f633531149128a7d716c51152a5a">
      <journal-id journal-id-type="nlm-ta">Sciresol</journal-id>
      <journal-id journal-id-type="publisher-id">Sciresol</journal-id>
      <journal-id journal-id-type="journal_submission_guidelines">https://jmsh.ac.in/</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Sciences and Health</journal-title>
      </journal-title-group>
      <issn publication-format="print"/>
    </journal-meta>
    <article-meta id="article-meta-13bfa05f4f8142589a512a6b52ff9345">
      <article-id pub-id-type="doi">10.46347/jmsh.v8i2.21.188</article-id>
      <article-categories>
        <subj-group>
          <subject>CASE SERIES</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title id="article-title-be9267f2b5cd4854b4e8825b16662a67">Unusual Violet Coloured Pigment Produced by <italic id="e-0493ef606ac1">Burkholderia cepacia</italic> Complex – A Report of Five Cases from a Tertiary Care Hospital in Mumbai</article-title>
        <alt-title alt-title-type="right-running-head">Unusual violet coloured pigment produced by Burkholderia cepacia complex</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name id="name-52645e44e3db46f3ba3d59caad48549e">
            <surname>De</surname>
            <given-names>Anuradha</given-names>
          </name>
          <email>dranuradhade@gmail.com</email>
          <xref id="xref-4d2d33bae97148ec8b270652dc75354b" rid="aff-fcc93f6509ca41a5805a0d37c59092f2" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-9f54dcadb6aa452a84dd2bbdb4fadacd">
            <surname>Shastri</surname>
            <given-names>Jayanthi S</given-names>
          </name>
          <xref id="xref-3afc8172c9224200bc22694ecdec1be6" rid="aff-c00d4fca6f754ac4affd781cf59a20a5" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-a9da8810a77e4acc9de2b4ea03e78cf9">
            <surname>Malak</surname>
            <given-names>Nazneen I</given-names>
          </name>
          <xref id="xref-188ee12e6d5c4ce2b2bb58ecec425c9e" rid="aff-c09ce9bb1a004dc8b987262f586f65e3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-ac4f4aeaec514d8d83b400a388e393d5">
            <surname>Kedia</surname>
            <given-names>Manali</given-names>
          </name>
          <xref id="xref-0fb8da457be1457aa09c8a2378021575" rid="aff-efbf3b90d9cd449095e4bbc5cfa0b4ef" ref-type="aff">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name id="name-3b4524122e654c24b2138259e804f740">
            <surname>Sisodia</surname>
            <given-names>Harshita</given-names>
          </name>
          <xref id="xref-ca4986d125ca4b06b5b8ae7c8807df62" rid="aff-0e2cf683ae5545f08a6424e8ac6d8647" ref-type="aff">5</xref>
        </contrib>
        <aff id="aff-fcc93f6509ca41a5805a0d37c59092f2">
          <institution>Ex Professor, Department of Microbiology, Topiwala National Medical College</institution>
          <addr-line>Mumbai, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="aff-c00d4fca6f754ac4affd781cf59a20a5">
          <institution>Professor and Head, Department of Microbiology, Topiwala National Medical College</institution>
          <addr-line>Mumbai, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="aff-c09ce9bb1a004dc8b987262f586f65e3">
          <institution>Assistant Professor, Department of Microbiology, Government Medical College</institution>
          <addr-line>Akola, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="aff-efbf3b90d9cd449095e4bbc5cfa0b4ef">
          <institution>Medical Officer, Department of Microbiology, District Hospital</institution>
          <addr-line>Akola, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
        <aff id="aff-0e2cf683ae5545f08a6424e8ac6d8647">
          <institution>Assistant Professor, Department of Microbiology, Topiwala National Medical College</institution>
          <addr-line>Mumbai, Maharashtra</addr-line>
          <country country="IN">India</country>
        </aff>
      </contrib-group>
      <volume>8</volume>
      <issue>2</issue>
      <fpage>173</fpage>
      <permissions>
        <copyright-year>2022</copyright-year>
      </permissions>
      <abstract id="abstract-abstract-title-cc568a2803e448a0a22ae1ff0709b2c4">
        <title id="abstract-title-cc568a2803e448a0a22ae1ff0709b2c4">Abstract</title>
        <p id="paragraph-f160ac9116c945209cad4f1c74bb6184"><italic id="e-35835e70ee3e">Burkholderia cepacia</italic> complex (BCC) represent a group of opportunistic organisms that cause a wide variety of infections including the nosocomial. The organism is found to cause sepsis and is also reported to cause blood stream infections in malignancy. Here, we present a case series of five patients with sepsis in which an unsual violet pigment producing BCC was isolated.</p>
        <p id="p-8e3b0e82ab69"/>
      </abstract>
      <kwd-group id="kwd-group-1c0f8fb561844440b4bfd5590cd539c9">
        <title>Keywords</title>
        <kwd>Violet pigment</kwd>
        <kwd>Burkholderia</kwd>
        <kwd>Sepsis</kwd>
        <kwd>Malignancy</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title id="title-c97f411e915c4ddb882adf280a64889f">Introduction</title>
      <p id="paragraph-c9c9625164b6456cafc19a42a5ce531e">Burkholderia is an aerobic gram negative, non-fermenting bacteria that is widely dispersed in both natural and man-made habitats. The species ‘cepacia’ was first described by Walter <italic id="e-11155995d89f">H. Burkholder</italic> in mid-1940 as a cause of onion rot.<sup id="superscript-5d8a7037bcf34cb7a1048c2967db425d"> </sup>There are 22 different species described under the genus Burkholderia. <sup id="superscript-b237b68765cf47d4979acbcac748cc76"><xref id="xref-e3e84945e6324c419a54f6aef995eaae" rid="R149280625614506" ref-type="bibr">1</xref></sup> <italic id="e-aca48f7f6971">Burkholderia cepacia</italic> is classified in 10 serovars that are collectively termed as <italic id="e-6763ce990099">Burkholderia cepacia</italic> complex (BCC).<sup id="superscript-d58b875836a540c3a73389b2550bd9b1"> </sup><xref id="xref-191ebfbe6ad241f5adbd60548575edc3" rid="R149280625614501" ref-type="bibr">2</xref><sup id="superscript-fc52161cca47472d9b61a433721b8ec8"> </sup></p>
      <p id="paragraph-022e80a3325c4af08206675a8cad80b2">The organism is known to cause infection in patients with cystic fibrosis, causes pneumonia, nosocomial infections noted as blood stream infections (BSI). BCC also causes infection in patients with various malignancies and those undergoing treatment for malignancies were also found to have BSI with BCC. <sup id="superscript-238ac3b8d59b44af8a983a5c3b926f25"><xref rid="R149280625614512" ref-type="bibr">3</xref>, <xref rid="R149280625614500" ref-type="bibr">4</xref>, <xref rid="R149280625614504" ref-type="bibr">5</xref></sup></p>
      <p id="paragraph-8e123041fc6b4945afb7480c7d1876ec">BCC is an opportunistic group, that is known to cause increased morbidity and mortality especially in hospitalised patients owing to its resistance to antibiotics.<sup id="superscript-de19f3a8cd834c5d9de9bda9ad362799"> </sup><xref id="xref-89b94cf8c6e34ec7b818328d79d33f79" rid="R149280625614503" ref-type="bibr">6</xref><sup id="superscript-c6b18cdfe53b428db7f90de1c6b4b0c2"> </sup>The oragnism’s natural tendency to colonise various surfaces, intra-venous sets, central-lines, nebulizers, respiratory devices and disinfectants makes it a major cause for small hospital outbreaks. <sup id="superscript-cda93b2b88dc4841ab7f923966698281"><xref id="xref-df6b52312f3c4af99ed1751f9483c313" rid="R149280625614513" ref-type="bibr">7</xref></sup> </p>
      <p id="paragraph-56da0ea559734096a458caba75fc395b">Here, we present a series of five cases where an unusual violet pigment producing BCC was identified. To the best of our knowledge this is the first case of violet pigment producing BCC from Mumbai. </p>
    </sec>
    <sec>
      <title id="t-02427695055e">
        <bold id="strong-10ad62925a59422a8a5949d6ae8386ac">Case History</bold>
      </title>
      <p id="paragraph-0aacfdb0a85b4c408369e7d91cf798f3">Relevant demographic characteristics and risk factors of five cases of sepsis were assessed and analyzed. This included age, sex, admitted in ward or intensive care unit (ICU), relevant clinical history, clinical co-morbidities, antibiotic treatment, exposure and duration of exposure to central venous access, history of indwelling devices and investigations done. These are depicted in <xref id="x-b1b6a8944107" rid="table-wrap-b4a4522011124b23a5ad3fb85789b98d" ref-type="table">Table 1</xref>. </p>
      <p id="paragraph-ee625bdc7bfe4f3da65d9728f526d5f2">In all the above mentioned five cases, laboratory diagnosis of sepsis was confirmed by blood culture. Blood samples were processed in BACTEC 9120 system. Subcultures were done on Blood agar and MacConkey agar plates from flash positive bottles and the plates were incubated overnight at 37<sup id="superscript-cfa3caad9b3a43ed88d9fe7b010497e4">0</sup>C. <sup id="superscript-2042452462794ed18c9822e76bcac2ae"><xref id="xref-854ee0c184264f588ccc87802d88dc75" rid="R149280625614499" ref-type="bibr">8</xref></sup> Phenotypic identification was done with Vitek 2 ID-GNB card (BioMérieux, India) from a private laboratory. Antimicrobial susceptibility test (AST) was performed by Kirby Bauer Disc Diffusion Method (KBDDM) on Mueller Hinton Agar (MHA), according to CLSI guidelines 2018. <sup id="superscript-b8dd60e76c2c48d48824127cf6c59f41"><xref id="xref-c4bdf7344d674132a1b7d9c162305781" rid="R149280625614511" ref-type="bibr">9</xref></sup> Antibiotic discs used were Meropenem (10µg), Cotrimoxazole (1.25/23.75µg), Ceftazidime (30µg), Gentamicin (30µg) and Polymyxin B (300U).</p>
      <p id="paragraph-3a7734066b054d59b006859b161bba4e">Culture on MacConkey Agar demonstrated growth of unusual violet colored pigmented colonies (<xref id="x-0fac77695eb2" rid="figure-c4dd96c8308942b1ad92ce1d1f1f51be" ref-type="fig">Figure 1</xref> a). The colonies were 0.5 - 1 mm in size, non-lactose fermenting, circular with entire edge and regular margins, in contrast to typical colonies of BCC. (<xref id="x-231f199a85ba" rid="figure-c4dd96c8308942b1ad92ce1d1f1f51be" ref-type="fig">Figure 1</xref> b &amp; c) show the violet coloured pigment on Nutrient Agar &amp; Blood Agar respectively. All the five isolates obtained had a similar morphological appearance and growth characteristics. <italic id="e-f01d69d3f125">Burkholderia cepacia</italic> complex was identified in blood cultures of all the five patients by Vitek 2 identification systems. All the isolates were sensitive to meropenem, cotrimoxazole and ceftazidime but were resistant to gentamicin and polymyxin B (<xref id="x-950623b25a61" rid="figure-c4dd96c8308942b1ad92ce1d1f1f51be" ref-type="fig">Figure 1</xref>d).</p>
      <table-wrap id="table-wrap-b4a4522011124b23a5ad3fb85789b98d" orientation="portrait">
        <label>Table 1</label>
        <caption id="caption-3ce727b0350844b98e20e06c985b0135">
          <title id="title-4e1145639b834c66a477fcdc4afae89d">Demographic characteristics and risk factors of five cases</title>
        </caption>
        <table id="table-22026faa698549fa89d1ad6d24a6f5a4" rules="rows">
          <colgroup>
            <col width="5.069999999999999"/>
            <col width="5.120000000000002"/>
            <col width="6.8700000000000045"/>
            <col width="16.910000000000004"/>
            <col width="9.499999999999998"/>
            <col width="18.269999999999996"/>
            <col width="11.680000000000003"/>
            <col width="14.989999999999997"/>
            <col width="11.590000000000002"/>
          </colgroup>
          <tbody id="table-section-86447db12cda48b09a72c3ae610c1fd9">
            <tr id="table-row-85244361a08140b0be1f6c7d2a9108e3">
              <td id="table-cell-176544a0d808488d9a7482db75f77ac1" align="left">
                <p id="paragraph-5ee35ef8dd404d11b11ff35f37a846e6"> <bold id="strong-33370cbbab4441b0b9538d3797f444d0">Sr No.</bold></p>
              </td>
              <td id="table-cell-8f41f4efe5d944748725a4802c29c2b2" align="left">
                <p id="paragraph-35ccedfce66e4b9d8b0fd38d6275ad7e"> <bold id="strong-78d09e14c218453a9c0eb80f69ab5dfa">Age/</bold> <bold id="strong-51a1a4885d2a482a915f2a7a6e8b3a85">Sex</bold></p>
              </td>
              <td id="table-cell-c80972bd3e8c4d03a527264eb2be5ce5" align="left">
                <p id="paragraph-a19c8545a4644efc880f3320d4eecce6"> <bold id="strong-bb0d094cf96642449f4e901ed7a45da0">ICU/</bold> <bold id="strong-60b8a45173774253aaca514be9708e94">Ward</bold></p>
              </td>
              <td id="table-cell-54fab475872b46e5ada560bd770e4196" align="left">
                <p id="paragraph-b795973a95524322ab3131d748380345"> <bold id="strong-7158e63270f64eca914398b6e6856626">Relevant clinical history</bold></p>
              </td>
              <td id="table-cell-405ac93c336e4eb4a877d8291b14b0e6" align="left">
                <p id="paragraph-7ab7de4c20ff4095908668f900c406fb"> <bold id="strong-b2b4366513a84879b6d941dd71063318">Indwelling device (CVA or Catheter)</bold></p>
              </td>
              <td id="table-cell-cd6c5203591b4721b5fdf4de070ff2a1" align="left">
                <p id="paragraph-a6217e27c97742a9bab0c23e1519ba61"> <bold id="strong-89b3ab288e2b40d38d5b1c95699963da">Other investigations</bold></p>
              </td>
              <td id="table-cell-e34dd1cbdfd24143a167186306c33d50" align="left">
                <p id="paragraph-80047bcbe9a84bd1b3dfcdf70fa575c0"> <bold id="strong-0164e2ff51e745fa9df3bc7db1ae5249">Diagnosis</bold></p>
              </td>
              <td id="table-cell-09876b66e48f4fcda13e20b1e17753b2" align="left">
                <p id="paragraph-7968a2a6cf124098abae0fe9b9fb7a80"> <bold id="strong-3aee1964d0b24df38c396e9e11767efa">Antibioitcs</bold> <bold id="strong-f02648f89bac44d287c3d9beab9e9d6e">Before (Antibiotic susceptibility report) ABS report</bold></p>
              </td>
              <td id="table-cell-98748bd5f36049c18c37393e19f9ab58" align="left">
                <p id="paragraph-9a4cdc7208b8453f8203a4331f521e26"> <bold id="strong-20b006054003480b9594423ad66d64b6">Antibiotics after ABS report</bold></p>
              </td>
            </tr>
            <tr id="table-row-97fd5d4f63174a4fa44b9f001cbc84a7">
              <td id="table-cell-35e3970b1cc043f6bc00071c6aee4ff3" align="left">
                <p id="paragraph-67cc952e8016466fbefbc606c0feb804"> 1.</p>
              </td>
              <td id="table-cell-22267eefe5724a3e8fad67163d91befb" align="left">
                <p id="paragraph-d51ab8d170b543e4818492f65093bad3"> 57/M</p>
              </td>
              <td id="table-cell-44d6ae051737405ca4fe7dd21c908a79" align="left">
                <p id="paragraph-5c21da3b723640b8a2ac693ac6c08c52"> ICU</p>
              </td>
              <td id="table-cell-2f6f04b62dfd4943b704dc1b996f4958" align="left">
                <p id="paragraph-6c22ea006def433da1580d60921d19bb"> -History of highgrade fever post chemotherapy -History of platelet and blood cell transfusion -No history of diabetes or hypertension</p>
              </td>
              <td id="table-cell-4afefc39907c4d7f9fdfa5148db1af04" align="left">
                <p id="paragraph-44d22f0b68e142a39f7e32855ef5d79a"> Put on Mechanical ventilator for 2 days</p>
              </td>
              <td id="table-cell-f9585fb5c1e64fe8952826ea26b32a07" align="left">
                <p id="paragraph-86d94aff16974ce3a7833640831f9380"> <bold id="strong-fa20c465fe2642deb8075588cee73084">Flow Cytometry: </bold>Phenotypes- CD13, CD14, CD 11b, CD33,CD64, CD36, CD38, CD34, CD45, CD117, HLA-DR. <bold id="strong-2e6f41b4901946c3a33b98ab81668b7c">2D ECHO:</bold> Degenerative affection of aortic valve, Mild pulmonary hypertension <bold id="strong-4cf579c53c8541ddaab610d348858f4a">USG: </bold>Hepatomegaly with diffuse fatty liver <bold id="strong-ccc582c70c974e828c6d8f25eaeafe69">Peripheral blood smear: </bold>Blastocyte 6%, Promyelocyte 30%, Myelocyte 8%, Metamyelocyte 4%.</p>
              </td>
              <td id="table-cell-7cdc91ad65cc44adb7698364a5ff86e9" align="left">
                <p id="paragraph-463afa0e14104239af72d7f7d84519a9"> Acute Myeloid leukemia (AML), AML-M4</p>
              </td>
              <td id="table-cell-55bc7fab8fff4e5aa7bd0ed0bb76303d" align="left">
                <p id="paragraph-2f1c3565e9984fdbab03cb121d7c9746"> On chemotherapy plus Imipenem, Amphotericin B, Colistin</p>
              </td>
              <td id="table-cell-31b043f706974c8f8458d1555158810e" align="left">
                <p id="paragraph-67d9e0c043d24e39bb4db3745d42190e">Started on Ceftazidime, Cotrimoxazole and Continued with Inj Imipenem</p>
              </td>
            </tr>
            <tr id="table-row-ab5af8bb7c3c47098252b965044d1518">
              <td id="table-cell-b71b7a2f62054d06845a1315be47ee68" align="left">
                <p id="paragraph-0b6fbc34daf845d182ada40af1825f49"> 2.</p>
              </td>
              <td id="table-cell-e31a259a5f584cf88a2df92ec452ce4c" align="left">
                <p id="paragraph-35c2cf63127b4b21b1ea4c3bf3ca3e60"> 50/M</p>
              </td>
              <td id="table-cell-b60cb56182dd4ea7b7ad6fea72175eb0" align="left">
                <p id="paragraph-8d76d482fb9446ad94b9b37bc409b73d"> MICU</p>
              </td>
              <td id="table-cell-808303b9a3e440418b1c54b5956b137c" align="left">
                <p id="paragraph-ca611c7ad6e54d4487c3ea7a5840d05f"> -History of cough, expectoration, Breathlessness, hemoptysis and high grade fever -No history of diabetes or hypertension</p>
              </td>
              <td id="table-cell-5874c53c80314aa9a77f15b699dedbef" align="left">
                <p id="paragraph-fc1ca3b85c91470396bdf975892bcd0c"> -</p>
              </td>
              <td id="table-cell-3c5865d8a09d44a88657e0e1fbab92ec" align="left">
                <p id="paragraph-d33aaadb587b4bc1b83e436ef6218ebf"> <bold id="strong-d819c7f50d434b3baffbec0028b64ad1">Sputum for AFB:</bold> Negative <bold id="strong-f974148ab39949768c64e3dde3e06cd3">2D ECHO:</bold> Mitral valve prolapsed with mitral regurgitation with moderate pulmonary hypertension, LVEF- 25% <bold id="strong-dd8bb77c38fb476ba990d9d2b54ce566">HRCT:</bold> Patchy areas of consolidation in right lower lobe.</p>
              </td>
              <td id="table-cell-23cd2b0e81414841aceb2fd5b0ca7b37" align="left">
                <p id="paragraph-4a95574e9acb45bd946bcff6749aa29c"> Congestive Cardiac failure with mitral regurgitation with lower respiratory infection</p>
              </td>
              <td id="table-cell-059f3ad1b71d4ebebdf49d91458c391d" align="left">
                <p id="paragraph-7ebdce13d1034b61b99b7e5fba69d89e"> Inj piperacillin-tazobactam Inj frusemide, Inj levofloxacin  Tab. Digoxin Tab. Carvedilol</p>
              </td>
              <td id="table-cell-1d1f1e95c8a24ecd983a56d022321b8b" align="left">
                <p id="paragraph-d608a2b970b140fdaf3665e643a526bd"> Inj Meropenem Inj Cotrimoxazole Inj Ceftazidime, in addition to ongoing antibiotics</p>
              </td>
            </tr>
            <tr id="table-row-bf9e966806f54b8cab4a5a175dd1e58d">
              <td id="table-cell-47614db5328046788e8361a44b6ebf5a" align="left">
                <p id="paragraph-00b011cdb2944a8587e8c197a2a99687"> 3.</p>
              </td>
              <td id="table-cell-ef9b7cd6a5fe43b5bf743bc54dfbebf9" align="left">
                <p id="paragraph-28175842cf85426c9124db5f395c6241"> 53/F</p>
              </td>
              <td id="table-cell-0fe684fbeb774ec78eb23c9a0c06a83b" align="left">
                <p id="paragraph-ce2f01bcb5e34fa98d0f2eb2f3c6fe52"> Medicine Ward</p>
              </td>
              <td id="table-cell-e68a9e44bc294e2b94024863c4642fe3" align="left">
                <p id="paragraph-7e56ea5c23944e8cb1b1ee0ff0450b7a"> -Chest pain and fever with chills -No history of diabetes mellitus and hypertension</p>
              </td>
              <td id="table-cell-0b86c728984e445f885c0aa2f99fb2fc" align="left">
                <p id="paragraph-2af4ebde67924411a8a76637c3fa1499"> -</p>
              </td>
              <td id="table-cell-5be45259ab074239a7be2048e1b4e906" align="left">
                <p id="paragraph-4ffd168957a8448fb58ec93677de5124"> <bold id="strong-6616836b20244473b290f46c90429b51">2D ECHO:</bold> Atrial fibrillation, Tricuspid regurgitation, LVEF- 30%</p>
              </td>
              <td id="table-cell-ed4f2e2db89b40389bd5397844d24409" align="left">
                <p id="paragraph-35118c23c1ce4efaaf84686146fc08eb"> Rheumatic heart disease</p>
              </td>
              <td id="table-cell-797feaa4b3034116823da0926850b699" align="left">
                <p id="paragraph-12a953a7012648c6a3e771f10f9a6e98"> Tab. Prolomet Tab. Warfarin</p>
              </td>
              <td id="table-cell-05b756999b7e4cef9b70259c8a74d10b" align="left">
                <p id="paragraph-5be40d08b665419eafe6059ae3a23077"> Inj Meropenem Inj Cotrimoxazole Inj Ceftazidime, in addition to ongoing treatment</p>
              </td>
            </tr>
            <tr id="table-row-2bfcd3ea97514a03bc051add39ae5850">
              <td id="table-cell-dce3b92b36e14bd6b7b16c7a7fa3ac8c" align="left">
                <p id="paragraph-6b40dd61227f4c3eb5267df837184fd3"> 4.</p>
              </td>
              <td id="table-cell-8f9520d3a7fd43e2b4f51debb9ad3274" align="left">
                <p id="paragraph-63be4fca78de4c5aa223bbf5f020a9d5"> 55/M    </p>
              </td>
              <td id="table-cell-752c27e295d84b1186315541167430bc" align="left">
                <p id="paragraph-eb291dd64ddd48cd84f52a30dd83e392"> MICU</p>
              </td>
              <td id="table-cell-559395254ccf4f5db582f93023739278" align="left">
                <p id="paragraph-7b09f9eb545f4b86898a68247d5566a3"> -History of breathlessness, nausea, blood in vomitus and stool -No history of diabetes mellitus and hypertension</p>
              </td>
              <td id="table-cell-62d9186f24114e3f933c12904629ba28" align="left">
                <p id="paragraph-dc75bdac6f1e451ebf37c22d7f5b7956"> -</p>
              </td>
              <td id="table-cell-6e8a4c06b4b348a298745935141974cf" align="left">
                <p id="paragraph-3e991a81ed2a4dfea78777ee6b71fc3f"> <bold id="strong-1fbb68777d184013a01aaa207e9dbbda">2D ECHO</bold>: mitral stenosis ,mild mitral valve regurgitation and prolapse, LVEF- 30%    </p>
              </td>
              <td id="table-cell-d01aa06d6928424497221d8b48a6f658" align="left">
                <p id="paragraph-4448cca9041c483fafb9347c6e2cddf7"> Rhuematic Heart Disease with Warfarin Toxicity With Upper GI Bleed </p>
              </td>
              <td id="table-cell-98b233e69d9f4bf6bce97e17eab3b171" align="left">
                <p id="paragraph-bc5dd5e29c564ebb83e50919a474e939"> Tab. Diazepam Inj vitamin K, Inj Lasix Tab. Prolomet</p>
              </td>
              <td id="table-cell-6bcabc42e6fa49af809cad8233b82ffb" align="left">
                <p id="paragraph-bb920a26ddf64aa2b517cf0bd0cc4eb5"> Inj Meropenem, in addition to ongoing treatment</p>
              </td>
            </tr>
            <tr id="table-row-257611c9e61245e29550bf9c4da0b844">
              <td id="table-cell-4decefbd48964e2e8663de6941641555" align="left">
                <p id="paragraph-fe02f9723397493a85d49c4eecdbcd40"> 5.</p>
              </td>
              <td id="table-cell-e9f8f65aab724a48ae0e3048f7534d22" align="left">
                <p id="paragraph-9aea355e24d84280bb8156b83dd1f0c8"> 47/F      </p>
              </td>
              <td id="table-cell-91d67f36344d415dbded34542206b78d" align="left">
                <p id="paragraph-ce55557efbf44686967956abb44ff1a9"> MICU</p>
              </td>
              <td id="table-cell-1bf5d8003ab440079912ca64fa5ca9b1" align="left">
                <p id="paragraph-4259377a6b704114a668bf99fe006b80"> History of breathlessness , pain in abdomen , pedal edema Known case of diabetes mellitus -No history of hypertension</p>
              </td>
              <td id="table-cell-894c5976b7ff4997b3a3e536f3db03bc" align="left">
                <p id="paragraph-44702314b32b41ee962d235815f5c54c"> -</p>
              </td>
              <td id="table-cell-9748832649684426a188a2e5cc3a5d0b" align="left">
                <p id="paragraph-10d23492e1b24b33baf074998d36eb30"> <bold id="strong-d24ca52e72d640298132f91e2d90222d">USG abdomen &amp; pelvis:</bold> suggestive of renal infract and mesentric vessel thrombosis. </p>
              </td>
              <td id="table-cell-daf82b4bbd764858bd66ca51331d416e" align="left">
                <p id="paragraph-0091715257c5483983f765b0c4a767a8"> Known case of Rheumatic Heart Disease</p>
              </td>
              <td id="table-cell-8aab006511c24c1493232f6f29d5f3b0" align="left">
                <p id="paragraph-837dd01c00fa47d39774fa701efd5577"> Inj ceftriaxone, inj dopamine, inj digoxin,  inj heparin, </p>
              </td>
              <td id="table-cell-b323310d85384791bba5ced0f3cbdf96" align="left">
                <p id="paragraph-1352ebbfbb8d488d99a92fc26d0d2e35"> No change in treatment            </p>
              </td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p id="paragraph-cdd72eb0771d4e3aa4e64de30976c713"/>
      <fig id="figure-c4dd96c8308942b1ad92ce1d1f1f51be" orientation="portrait" fig-type="graphic" position="anchor">
        <label>Figure 1 </label>
        <caption id="caption-7b379ad93fc449e7b37998112e2b106c">
          <title id="title-505c6999443345338ec35cb4481b5d43">Conventional Culture<bold id="strong-7643f2da11cf429c8cc4d638a19e65fc"> </bold>a- Violet coloured pigment on MacConkey Agar, b- Violet coloured pigment on Nutrient Agar, c- Violet coloured pigment on Blood Agar, d- ABS of BCC on Mueller Hinton Agar</title>
        </caption>
        <graphic id="graphic-ae95cc262b6c4f818eb74dff2871b75e" xlink:href="https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/6839bada-ab79-496f-8ddf-e1c7285fd13eimage1.jpeg"/>
      </fig>
    </sec>
    <sec>
      <title id="title-6bc8b5fa0f33425d91ae992432c34cd2">Discussion</title>
      <p id="paragraph-1ffb3b27f3864af2bb4683696b3369ae">BCC are gram negative bacteria belonging to β proteobacterium subdivision. They are notorious opportunistic pulmonary pathogen commonly infecting patients suffering from chronic granulomatous diseases and cystic fibrosis. Due to its ability to thrive in the diverse range of environments, BCC contributes to increased morbidity and mortality in hospitalized patients. Various outbreaks of BCC septicemia are seen in hospitalized patients – both immunocompetent and  immunosuppressed, as well in ICUs and oncology units.<sup id="superscript-c858fae490a04ecca82e195e9953aba9"> </sup><sup id="superscript-cb6577c83f304fdb8c72e399277593eb"><xref id="xref-3eede8b0e4454339908577a35fa07092" rid="R149280625614509" ref-type="bibr">10</xref> </sup></p>
      <p id="paragraph-287bed853fc84473a4923d5c84bf533a">Patients with nosocomial infections, cystic fibrosis, those with indwelling catheters and on ventilators should all raise a suspicion for BCC bacteremia.<sup id="superscript-56f32f477ef64af7a29c6152e6fd631c"> </sup>Patients with cystic fibrosis and having colonisation with BCC have progressive, fatal and reduced survival time, leading to ‘cepacia syndrome’ in many cases as compared with non-colonised BCC. <sup id="superscript-f74d70e2f4b04c5db2de08ea13b6a6a4"> </sup>In non-cystic fibrosis patients, BCC causes pneumonia, urinary tract infections, bloodstream infections and meningitis, endocarditis and malignant conditions like AML. <sup id="superscript-677487027f6f47059c7f729175bc38fa"><xref rid="R149280625614508" ref-type="bibr">11</xref>, <xref rid="R149280625614505" ref-type="bibr">12</xref></sup></p>
      <p id="paragraph-770ef48356bb432bac0ccee7714dc555">Owing to the wide distribution and survival in different environment, this pathogen has a tendency to cause nosocomial infections and hospital outbreaks. Studies show that BCC isolation has been found from iv solutions, nebulisation solutions, contaminated medicines etc.<sup id="superscript-00d4b784c9b84cdc9427d9e9a88864bf"> </sup><xref id="xref-22695f648a184b88a2cd4f5ba0fdce50" rid="R149280625614507" ref-type="bibr">13</xref></p>
      <p id="paragraph-35abcc0c54c14b0da991183830854f40"><italic id="e-ab21fa710e98">Burkholderia cepacia</italic> complex is intrinsically resistant to polymyxin and also show increasing multi-drug resistance,<sup id="superscript-18579168fe27448994a8606c7ef1b6a1"> </sup><xref id="xref-d40e9b571b4b42dda4446157718e5a33" rid="R149280625614514" ref-type="bibr">14</xref> which makes it a notorious pathogen to treat in critically ill and ICU patients. </p>
      <p id="paragraph-b68019d7c8954c57b7f9f07b8f9d019f">In all the five cases, the isolated colonies showed violet pigment production which was a unique feature shown by members of <italic id="e-77c390be55b9">Burkholderia cepacia</italic> complex. This is supported in a study by Rastogi et al <sup id="superscript-e512856a1d4b414b8c9e1fc67a7359a9"><xref id="xref-3b449a66b1074c648b51685abc7a5235" rid="R149280625614502" ref-type="bibr">15</xref></sup> and Ranjan et al <sup id="superscript-b1ae732f3f864490ba3aa5e4c344326d"><xref id="xref-e55e6707c74b42eca39c5e169aac5782" rid="R149280625614510" ref-type="bibr">16</xref></sup><sup id="superscript-55989e7ee9e543af8e277b1ff6eafc0e"> </sup>which also highlights the violet pigment producing BCC from blood cultures.</p>
      <p id="paragraph-7695ccc1a21e4599ae73c56830acea9c">Extensive study and literature on the phenotypic and genotype of various Burkholderia species need to be studied to know the cause of such diversity in its appearance. </p>
      <p id="paragraph-e332607c9742454ba98613ef77f88f7c">This is probably the first study from Mumbai showing violet color pigment producing <italic id="e-3da46f248974">Burkholderia cepacia</italic> complex.</p>
    </sec>
    <sec>
      <title id="title-f320fb53d52c4e248afa31438e9ad2e0">Conclusion</title>
      <p id="paragraph-832dd58f84814180b622237242d524f3"><italic id="e-6875c737a1e7">Burkholderia cepacia </italic>complex are most commonly found in association with hospital acquired infections. However we have come across five cases of sepsis caused by this pathogen producing an unusual violet colored pigment.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="R149280625614506">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ragupathi</surname>
              <given-names>N K</given-names>
            </name>
            <name>
              <surname>Veeraraghavan</surname>
              <given-names>B</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update</article-title>
          <source> Annals of clinical microbiology and antimicrobials</source>
          <year>2019</year>
          <volume>18</volume>
          <uri>https://doi.org/10.1186/s12941-019-0306-0</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614501">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Singhal</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Shah</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Naik</surname>
              <given-names>R</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Outbreak of Burkholderia cepacia complex bacteremia in a chemotherapy day care unit due to intrinsic contamination of an antiemetic drug</article-title>
          <source>Indian Journal of Medical Microbiology</source>
          <year>2015</year>
          <volume>33</volume>
          <issue>1</issue>
          <fpage>117</fpage>
          <lpage>119</lpage>
          <issn>0255-0857</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.4103/0255-0857.148405</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614512">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Durham</surname>
              <given-names>Spencer H</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Amy E</given-names>
            </name>
            <name>
              <surname>Assanasen</surname>
              <given-names>Chatchawin</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Burkholderia cepacia Septicemia in a Pediatric Oncology Patient: A Pharmacotherapy Challenge</article-title>
          <source>Annals of Pharmacotherapy</source>
          <year>2012</year>
          <volume>46</volume>
          <issue>6</issue>
          <fpage>e16</fpage>
          <issn>1060-0280</issn>
          <publisher-name>SAGE Publications</publisher-name>
          <uri>https://doi.org/10.1345/aph.1r015</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614500">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baul</surname>
              <given-names>Shuvra Neel</given-names>
            </name>
            <name>
              <surname>De</surname>
              <given-names>Rajib</given-names>
            </name>
            <name>
              <surname>Mandal</surname>
              <given-names>Prakas Kumar</given-names>
            </name>
            <name>
              <surname>Roy</surname>
              <given-names>Swagnik</given-names>
            </name>
            <name>
              <surname>Dolai</surname>
              <given-names>Tuphan Kanti</given-names>
            </name>
            <name>
              <surname>Chakrabarti</surname>
              <given-names>Prantar</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Outbreak of Burkholderia cepacia infection: a systematic study in a hematolooncology unit of a tertiary care hospital from eastern India</article-title>
          <source>Mediterranean Journal of Hematology and Infectious Diseases</source>
          <year>2018</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>e2018051</fpage>
          <publisher-name>Institute of Hematology, Catholic University</publisher-name>
          <uri>https://doi.org/10.4084%2FMJHID.2018.051</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614504">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sapkota</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ganesan</surname>
              <given-names>S K</given-names>
            </name>
            <name>
              <surname>Priyadarshini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Tripathi</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Savitha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bhattacharjee</surname>
              <given-names>S</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Clinical Spectrum of Burkholderia cepacia Infection in Cancer Patients: A Retrospective Study of an Emerging Disease</article-title>
          <source>Med Microbiol Rep</source>
          <year>2018</year>
          <volume>2</volume>
          <fpage>1</fpage>
          <lpage>4</lpage>
        </element-citation>
      </ref>
      <ref id="R149280625614503">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rhodes</surname>
              <given-names>K A</given-names>
            </name>
            <name>
              <surname>Schweizer</surname>
              <given-names>H P</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Antibiotic resistance in Burkholderia species</article-title>
          <source>Drug Resistance Updates</source>
          <year>2016</year>
          <volume>28</volume>
          <fpage>82</fpage>
          <lpage>90</lpage>
          <uri>https://doi.org/10.1016/j.drup.2016.07.003</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614513">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bilgin</surname>
              <given-names>Huseyin</given-names>
            </name>
            <name>
              <surname>Gelmez</surname>
              <given-names>Gülşen Altınkanat</given-names>
            </name>
            <name>
              <surname>Bayrakdar</surname>
              <given-names>Fatma</given-names>
            </name>
            <name>
              <surname>Sayın</surname>
              <given-names>Elvan</given-names>
            </name>
            <name>
              <surname>Gül</surname>
              <given-names>Fethi</given-names>
            </name>
            <name>
              <surname>Pazar</surname>
              <given-names>Nazlı</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <article-title>An Outbreak Investigation of Burkholderia Cepacia Infections Related With Contaminated Chlorhexidine Mouthwash Solution in a Tertiary Care Center in Turkey.</article-title>
          <source>Antimicrobial Resistance &amp; Infection Control</source>
          <year>2021</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>1</fpage>
          <lpage>6</lpage>
          <publisher-name>Research Square Platform LLC</publisher-name>
          <uri>https://doi.org/10.1186/s13756-021-01004-8</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614499">
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Procop</surname>
              <given-names>G W</given-names>
            </name>
            <name>
              <surname>Church</surname>
              <given-names>D L</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>G S</given-names>
            </name>
            <name>
              <surname>Janda</surname>
              <given-names>W M</given-names>
            </name>
            <name>
              <surname>Koneman</surname>
              <given-names>E W</given-names>
            </name>
            <name>
              <surname>Schreckenberger</surname>
              <given-names>P C</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <person-group person-group-type="editor"/>
          <source>Koneman's Color Atlas and Textbook of Diagnostic Microbiology</source>
          <edition>7</edition>
          <publisher-name>Williams &amp; Wilkins</publisher-name>
          <publisher-loc>Philadelphia</publisher-loc>
          <year>2017</year>
          <fpage>233</fpage>
          <lpage>265</lpage>
        </element-citation>
      </ref>
      <ref id="R149280625614511">
        <element-citation publication-type="misc">
          <person-group person-group-type="author">
            <collab/>
          </person-group>
          <article-title>9.Performance Standards for Antimicrobial Susceptibility Testing, M100S. Clinical &amp; Laboratory Standards Institute 2018; M02 A12,M 07 A10,M11-A8</article-title>
          <fpage>56</fpage>
          <lpage>68</lpage>
        </element-citation>
      </ref>
      <ref id="R149280625614509">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenna</surname>
              <given-names>Dervla T D</given-names>
            </name>
            <name>
              <surname>Lilley</surname>
              <given-names>Daniel</given-names>
            </name>
            <name>
              <surname>Coward</surname>
              <given-names>Amy</given-names>
            </name>
            <name>
              <surname>Martin</surname>
              <given-names>Kate</given-names>
            </name>
            <name>
              <surname>Perry</surname>
              <given-names>Claire</given-names>
            </name>
            <name>
              <surname>Pike</surname>
              <given-names>Rachel</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <article-title>Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients</article-title>
          <source>Journal of Medical Microbiology</source>
          <year>2017</year>
          <volume>66</volume>
          <issue>4</issue>
          <fpage>490</fpage>
          <lpage>501</lpage>
          <issn>0022-2615</issn>
          <publisher-name>Microbiology Society</publisher-name>
          <uri>https://doi.org/10.1099/jmm.0.000458</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614508">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ki</surname>
              <given-names>Hyun Kyun</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>Sung Hea</given-names>
            </name>
            <name>
              <surname>Han</surname>
              <given-names>Seong Woo</given-names>
            </name>
            <name>
              <surname>Cheong</surname>
              <given-names>Hae Suk</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>A case of native valve endocarditis caused by Burkholderia cepacia without predisposing factors</article-title>
          <source>BMC Infectious Diseases</source>
          <year>2011</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>114</fpage>
          <publisher-name>Springer Science and Business Media LLC</publisher-name>
          <uri>https://doi.org/10.1186%2F1471-2334-11-114</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614505">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mihaila</surname>
              <given-names>Romeo-Gabriel G</given-names>
            </name>
            <name>
              <surname>Blaga</surname>
              <given-names>Lucian</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Burkholderia cepacia septicemia in a patient with acute myeloid leukemia in postchemotherapy bone marrow aplasia</article-title>
          <source>Pakistan Journal of Medical Sciences</source>
          <year>2013</year>
          <volume>29</volume>
          <issue>5</issue>
          <fpage>1275</fpage>
          <lpage>1277</lpage>
          <publisher-name>Pakistan Journal of Medical Sciences</publisher-name>
          <uri>https://doi.org/10.12669%2Fpjms.295.3485</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614507">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Magalhães</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Doherty</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Govan</surname>
              <given-names>J R</given-names>
            </name>
            <name>
              <surname>Vandamme</surname>
              <given-names>P</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Polyclonal outbreak of Burkholderia cepacia complex bacteraemia in haemodialysis patients</article-title>
          <source>Journal of Hospital Infection</source>
          <year>2003</year>
          <volume>54</volume>
          <issue>2</issue>
          <fpage>120</fpage>
          <lpage>123</lpage>
          <uri>https://doi.org/10.1016/s0195-6701(03)00118-x</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614514">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gautam</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Singhal</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ray</surname>
              <given-names>P</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Burkholderia cepacia complex: Beyond pseudomonas and acinetobacter</article-title>
          <source>Indian Journal of Medical Microbiology</source>
          <year>2011</year>
          <volume>29</volume>
          <issue>1</issue>
          <fpage>4</fpage>
          <lpage>12</lpage>
          <issn>0255-0857</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.4103/0255-0857.76516</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614502">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rastogi</surname>
              <given-names>Neha</given-names>
            </name>
            <name>
              <surname>Khurana</surname>
              <given-names>Surbhi</given-names>
            </name>
            <name>
              <surname>Veeraraghavan</surname>
              <given-names>Balaji</given-names>
            </name>
            <name>
              <surname>Inbanathan</surname>
              <given-names>Francis Yesurajan</given-names>
            </name>
            <name>
              <surname>Sekar</surname>
              <given-names>Suresh Kumar Rajamani</given-names>
            </name>
            <name>
              <surname>Gupta</surname>
              <given-names>Deepak</given-names>
            </name>
            <collab/>
            <etal/>
          </person-group>
          <article-title>Epidemiological investigation and successful management of a Burkholderia cepacia outbreak in a neurotrauma intensive care unit</article-title>
          <source>International Journal of Infectious Diseases</source>
          <year>2019</year>
          <volume>79</volume>
          <fpage>4</fpage>
          <lpage>11</lpage>
          <issn>1201-9712</issn>
          <publisher-name>Elsevier BV</publisher-name>
          <uri>https://doi.org/10.1016/j.ijid.2018.10.008</uri>
        </element-citation>
      </ref>
      <ref id="R149280625614510">
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ranjan</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Chowdhary</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kamra</surname>
              <given-names>A</given-names>
            </name>
            <collab/>
          </person-group>
          <article-title>Community Acquired Burkholderia cepacia Bacteraemia Presenting as MODS in an Immunocompetent Individual: An Unusual Case</article-title>
          <source>Journal of Clinical and Diagnostic Research</source>
          <year>2017</year>
          <volume>11</volume>
          <issue>3</issue>
          <fpage>1</fpage>
          <lpage>2</lpage>
          <issn>2249-782X</issn>
          <publisher-name>JCDR Research and Publications</publisher-name>
          <uri>https://doi.org/10.7860%2FJCDR%2F2017%2F16285.9435</uri>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
